SynBioBeta Speaker
Benedetta Di Robilant
Co-founder & CEO
ProMIND Therapeutics
May 2026, SynBioBeta
Speaker
Dr. Benedetta di Robilant is a biotech entrepreneur and scientist with a PhD in Immunology and a Postdoctoral Fellowship at Stanford University, where she studied stem cells, aging, and age-related diseases including Down syndrome, Alzheimer’s disease, and fibrosis. She has experience translating academic discoveries into biotech ventures. Dr. di Robilant previously founded Dorian Therapeutics, a Stanford spinout acquired by Altos Labs and is now the co-founder and CEO of ProMIND Therapeutics, developing first-in-class therapies for neurodegenerative and neurodevelopmental disorders. Her work sits at the intersection of aging, neuroscience and translational medicine, with a focus on advancing fundamental discoveries toward meaningful patient impact.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.